August 7, 2026 · Perspective · Heart Failure Prevention
CKM Staging: A Paradigm Shift in Cardiovascular Care
The new Cardiovascular-Kidney-Metabolic (CKM) staging framework from the ACC/AHA represents one of the most important shifts in cardiovascular medicine in decades.
Instead of waiting for heart failure, chronic kidney disease, or a cardiovascular event to develop, CKM encourages us to identify patients much earlier; when obesity, diabetes, hypertension, kidney dysfunction, or metabolic risk first emerge and intervene before irreversible damage occurs.
This is a move from treating established disease to preventing disease progression.
CKM reminds us that the heart, kidneys, and metabolic system are deeply interconnected. Managing one in isolation is no longer enough. Early recognition, multidisciplinary care, and aggressive risk factor modification can change the trajectory of a patient's health.
As clinicians, regardless of specialty, we all need to become familiar with CKM staging. It provides a common language for identifying risk, guiding therapy, and ultimately preventing heart failure, kidney disease, myocardial infarction, and stroke.
At Sharp, we have embraced this preventive philosophy by emphasizing early identification, multidisciplinary evaluation, optimization of guideline-directed therapies, obesity management, and coordinated care across the continuum. The future of cardiovascular medicine is not just treating disease; it is preventing it.
Important notice
This content is for educational purposes only and is not medical advice for any individual patient. Patients should discuss diagnosis and treatment decisions with their own physician, or request a clinical consultation.